The murine myeloid leukemia cell line M I induced by interleukin-6 (IL-6) is a model system to study the differentiation of blast cells to mature macrophages. We have recently shown that IL-6 induces the expression of the IL-4 receptor (IL-4R) in these cells. In the present study we investigate the mechanism of action of interferon-? (IFN-y) , an antagonist of IL-4 in numerous cells and a cofactor in both induction and suppression of myelopoiesis, on the expression of IL-4R. Flow cytometry shows that IFN-y downregulates the IL-6-induced expression of IL-4R whereas it has no such effect on the high-affinity receptors for monomeric lgG2a ( This is a US government work. There are no restrictions on its use.
T the clonal growth of myeloid progenitor provided a way to analyze the process of differentiation of myeloid progenitor cells into mature macrophages and granulocytes, a process that is regulated at various stages by specific ~ytokines.~ T cells produce essential cytokines such as interleukin-3 (IL-3), granulocyte-macrophage colonystimulating factor (GM-CSF), and IL-6 that directly affect myelopoiesis. Other T-cell-derived cytokines such as IG4 the murine myeloid leukemia M1 cell line, a well-established in vitro model to study the differentiation pathway from immature blast cells to mature macrophages." We have recently shown that IL-6 induces the expression of both membrane-bound and soluble IL4R (sIL-4R) in these cells as well as in normal BM-derived The present study was undertaken to investigate the potential effects of IFN-y on the expression of I L 4 R in M 1 cells during differentiation.
MATERIALS AND METHODS
Reagents. RPMI 1640 medium, Dulbecco's modified Eagle's medium (DMEM), glutamine, penicillin, streptomycin, and horse serum (HOS) were purchased from GIBCO Laboratories (Grand Island, NY). The serum was heat inactivated at 56°C for 30 minutes before use. Mouse IgG2a was purchased from Coulter Immunology (Hialeah, FL). Fluorescein isothiocyanate (FITC)-conjugated goat antimouse IgG antibodies F(ab'), and FITC-conjugated affinity purified goat antirat IgG F(ab'), were obtained from Cappe.1 (West Chester, PA). Recombinant human IL-6 (specific activity: 4 X IO6 U/mL) was kindly provided by Dr Steven Clark (Genetics Institute, Cambridge, MA). Recombinant murine IFN-7 (specific activity: IO' U/mL) was supplied by Genentech, Inc (San Francisco, CA). Recombinant murine IL-4, recombinant soluble IL-4R, the M 1 and M2 rat antimurine IL4R monoclonal antibodies, and the cDNA clone for IL4R (Muil4r-PR) were the generous gifts of Dr Steven Gillis (Immunex Corp, Seattle, WA). IL-4 had a specific activity of 10' U/mg protein. Micrococcus lysodeicticus, lysozyme 1 mmol/L glutamine, 100 U/mL penicillin, and 100 pg/mL streptomycin. The cells were passaged twice a week at 2 X IO' cells/mL. The cells were determined to be greater than 90% viable by trypan blue exclusion before each experiment.
Induction of differentiation. MI cells were induced to differentiate from blast cells into mature macrophages by culturing the cells at an initial concentration of 2 X I05/mL for up to 3 days in the presence of 20 ng/mL IL-6. Before each experiment, the adherent cells were detached by treatment for 10 minutes at 37°C with phosphate-buffered saline (PBS) containing 0.0 1 % EDTA. Differentiation was assessed morphologically by Giemsa staining and light microscopy. In brief, sample supernatants were added (100 pL) to duplicate wells of ELISA plates precoated with the M2 anti-lL4R antibody2' ( I pglwell in 100 pL). After rinsing, bound sIL-4R was detected with biotinylated M l anti-IL-4R antibody2' (20 pg/mL, 100 pL/well) followed by streptavidin labeled with horseradish peroxidase. Detection of bound, peroxidase-labeled streptavidin was performed with tetramethylbenzidine (TMB; Sigma) and the plates were analyzed at 650 nm in a microplate reader. Titrated samples were compared with a titration curve ofrecombinant soluble IL-4R to quantitate soluble IL-4R levels in the supernatants. The results, normalized to IO6 cells, are expressed as the mean of two experiments performed in duplicate.
Flow cytometric measurements of
IL-4 was labeled with Iz5I by the lactose peroxidase method using Enzymobeads (BioRad Laboratories, Richmond, CA) as previously described." One millicurie of camerfree Na-"'l was used to label 20 pg of protein. After 25 minutes at room temperature, the material was passed over a P6 column (BioRad) to separate free from bound iodine. The specific activity of radiolabeled l L 4 was estimated to be 5 to 8 X IO" cpm/mg based on a molecular weight of IL-4 of 17,000 daltons, as determined by sodium dodecyl sulfate-polyacrylamide gel analysis (SDS-PAGE). The bioactivity of IL-4 remained unaltered by the iodination procedure, based on proliferation experiments with the IL-4-dependent CT.4S cell line (kindly provided by D r W.E. Paul, National Institutes of Health, Bethesda, MD).
Binding studies were performed as previCells and cell culture.
Binding experiments. Cell-bound '"I-labeled protein was separated from unbound (free) radiolabeled material by centrifugation ( 10,000g for 3 minutes) of 50 pL duplicate aliquots through a layer of phthalate oil (Fisher Scientific, Fair Lawn, NJ)z6 in 400-pL polyethylene tubes. The tips of these tubes containing the cell pellet were cut off and radioactivity was measured in an LKB gamma counter (Wallac, Oy, Finland). Radioactivity in the liquid phase was counted to determine the unbound fraction. The number of molecules bound per cell and their affinity were calculated by equilibrium analysis as described by S~atchard.~' Data were analyzed by linear regression analysis as described by Snedecor and Cochran." cDN.4 prohcs. The 673-bp fragment specific for IL4R cDNA was released from Mui14r-PR6 with k h R 1 and fsrl from its pRluescript vector (Stratagene. La Jolla. CA). The DI 3-2 mouse high-affinity IgG receptor (FcyRI) cDNA was a gift from Dr Duane W. Scars (Department of Biological Sciences, University ofCalifornia. Santa Barbara)": the 1.3-kb insert was isolated from its pGEXll vector by BnmHI digestion. The cDNA for mouse lysozyme M cloned into the Rluescribe M I3+ vector was kindly provided by Dr Michael Cross (Max-Planck-Institute fur Riochemie. Martinsried. Germany)? the 780-bp insert was isolated by EcoRI digestion. The cDNA for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) pRGAPD-I3 has been previously described": the insert was isolated by Rsrl digestion. The probes were radioactively labeled with R-[~'P] dCTP to specific activities of 2 to 3 X IO9 cpmlpg with the large fragment of DNA polymerase I using random hexamers as primers.." h'orrlrcw? crno/jsi.s. Total cellular RNA was isolated by a singlestep isolation method." RNA was electrophoresed on 1% agarose gels containing 1% formaldehyde and transferred to Nytran membranes (Schleicher and Schuell. Keene. NH). After transfer, the RNA was cross-linked to the membrane by U V light (UV Stratalinker: Stratagene. La Jolla. CA). The membranes were prehybridized in a solution containing 500 mmol/L sodium phosphate (pH 7.0). I mmol/L EDTA. 1% RSA and 0.1% SDS at 65°C. The membrane-bound RNA was hybridized with the radiolabeled probes under the same conditions. The membranes were washed twice in 2X standard saline citrate (SSC). 0.1% SDS. twice in 0 . 5~ SSC. 0. I% SDS for I5 minutes each at room temperature and twice for I5 minutes in 0. I x SSC, 0.1% SDS at 65°C and then exposed to Kodak XAR film (Eastman Kodak. Rochester, NY) at -70°C for different time intervals using intensifying screens. The probe was removed by incubating the membrane in a solution of 50% formamide and 6X SSC at 65°C for I8 hours followed by a rinse in 2 x SSC before hybridizing the same membrane with the next probe. The probe for the constitutively expressed GAPDH was used as a control for the amount of RNA loaded on each lane. Actinomycin-D chase experiments were performed as previously described." Briefly. cells were treated with the respective cytokines, and after48 hours RNA synthesis was inhibited with actinomycin-D ( 5 pg/mL) for various time periods up to 4 hours. Total RNA was extracted and submitted to Northern analysis as described above. Relative mRNA levels (percent ofthe initial ratio of IL-4R vGAPDH) were plotted based on densitometric scanningofthe autoradiograph. Signal intensities in these experiments were quantitated by image analysissoftware (NIH Image version I .47) afterscanning the filmswith a Microtek scanner (Microtek Laboratories Inc. Torrance, CA).
Transcriptional ana/jsis. Nuclear run-on transcription assays were performed according to the method of Groudine et al." Nuclei were prepared by lysing IO" cells for 5 minutes on ice in a buffer 2643 ( 10 mmol/L Tris HCI pH 7.4.3 mmol/L CaCI,, 2 mmol/L MgCI,) containing 0.2'70 NP-40. Denatured cDNA plasmids (10 pg/slot) were blotted onto Nytran using a slot-blot apparatus (Schleicher and Schuell). After prehybridization, the membrane-bound DNAs were hybridized at 65°C with the '2P-labeled RNA that was generated from 5 X 10' nuclei in vitro. After washing at high stringency and RNase A digestion (IO pglmL), membranes were exposed to Kodak XAR film at -70°C. Signal intensities were analyzed by scanning densitometry as described above for actinomycin-D chase experiments. FcyRI; 3. lysozyme; 4. GAPDH. The blots were exposed to Kodak XAR film at -70°C using intensifying screens. The GAPDH cDNA probe was used as an internal control. As determined by flow cytometry, unstimulated MI cells express IL-4R at a low level (Fig I) . IL-6 induces a strong increase in IL-4R expression over the first 24 hours followed by a more moderate increase up to 72 hours (Fig I) , in agreement with a previous report2' Treatment of MI cells with IFN-y slightly increases IL-4R expression. However, when MI cells are treated with a combination of IFN-y and IL-6. the level of IL-6-induced expression of IL-4R is markedly reduced (Fig I) . This suppressive effect of IFN-y is not universal. as IFN-y has no effect on IL-6-induced expression of FcyRI. As seen in Fig I , a low (Table I ). Upon treatment of these cells with either IL-6 or IFN-y, receptor expression increased IO-and 4-fold, respectively (Table I) . However, when the cells were treated with a combination of IL-6 and IFN-y. the induction of receptor expression was reduced by more than 50% compared with that of IL-6 alone (Table I) .
RESULTS

IFN-
No significant change in receptor affinity was noted by Scatchard analysis whereas receptor numbers changed from (Fig 2A) . We further compared the expression of IL-4R mRNA to the expression of mRNA of other IL-6-induced genes in M 1 cells such as FcyRl and lysozyme. Whereas mRNA for FcyRl is upregulated by both IL-6 and IFN-y (Fig 2B) , lysozyme mRNA is upregulated only by IL-6 (Fig 2C) . In neither case did the combined treatment of IL-6 with IFN-y downregulate mRNA expression. In the case of Fcy RI mRNA even higher levels were observed at 24 hours after the combined treatment (Fig 2B) . The expression of mRNA for GAPDH was not changed by the various treatments and thus serves as a control for the amount of RNA loaded in each lane ( Fig  2D) . IFN-y downregdates IL-6-induced transcription qf the IL-4R gene. Because Northern analysis showed that the effects of IFN-y and IL-6 on expression of IL-4R protein are paralleled by changes in steady-state levels of the corresponding mRNA. nuclear run-on assays were performed to determine the mechanism by which this suppression occurs. As shown in Fig 3, no specific The pUC8 vector was used as a control for nonspecific binding.
Actinomycin-D chase experiments were performed to evaluate a possible involvement of IL-4R mRNA destabilization in the downregulation of IL-6-induced IL-4R gene expression by IFN-y (Fig 4) . Based on scanning densitometry of the signals shown in Fig 4A, the half-life of IL4R mRNA was calculated to be 2 hours for both IL-6 and IL-6/ IFN-y treatment (Fig 4B) . Therefore. the downregulation of IL-4R cannot be attributed to differences in I L 4 R mRNA stability.
IFN-y downregirlales !he IL-6-indirccd prodticlion qf sIL-4R. Recently. we reported that the expression ofa soluble form of the IL4R (slL-4R) is inducible in M I cells by IL-6." Therefore, we determined whether IL-6-induced slL-4R production might be affected by treatment with IFN-7 in a similar fashion as cell bound IL-4R. As shown in Fig 5, IFN-y has been previously shown to regulate gene expression at both the transcriptional and posttranscriptional level. Several reports indicate that IFN-y can act by altering mRNA stability49 or by modifying the splicing of mRNA p r e c~r s o r s .~~ On the other hand, transcriptional regulation by IFN-y has been shown for the induction of FcyRI and Ia e x p r e s s i~n .~'~~~ As shown in the present study, the changes in IL4R protein expression are mediated predominantly by changes at the RNA level, although additional modifications at the translational or posttranslational level may still occur. These changes in mRNA in turn are shown to be regulated predominantly through a transcriptional mechanism. Supporting evidence is provided by actinomycin-D chase experiments that fail to demonstrate any change in mRNA stability after treatment of M 1 cells with IFN-7.
The expression of other IL-6-induced genes such as FcyRI and lysozyme, in contrast to IL4R, is not downregulated by the combined treatment with IL-6 and IFN-y. This would imply that the expression of the IL4R can be modulated independently from these markers of differentiation. We have observed a similar phenomenon for the expression ofthe IL-2R a-chain on M 1 cells that can also be modulated independently without altering the course of differentiation.34353 Such an independent modulation of cytokine receptors may enable the differentiating cell to respond and adapt to various changes in the surrounding tissue.
In this context it is of interest that the production of the soluble form of the IL4R is also affected by the treatment with IFN-y. There are different theories regarding the physiologic function of sIL-4R. On the one hand it has been shown to inhibit the effect of IL-4 both in vitro and in while on the other hand it is reported to act as a camer protein for IL-4.5s In the latter case a downregulation of responsiveness to IL-4 would require downregulation of both the membrane-bound and the soluble form of the receptor in a similar way, as is seen in MI cells. It is also conceivable that the inhibitory versus the stabilizing function of these soluble receptors is dependent on the compartment where they are present. Thus, a differentiating myeloid cell shedding sIL-4R may modulate the effect of IL-4 in its closest proximity (eg, BM) in one fashion whereas sIL-4R that has entered the circulation would modulate the systemic effects of IL-4 in an entirely different manner. In either case, the role that the regulation of expression of IL-4R and production of sIL-4R may play in myelopoiesis deserves further study.
